These initial observations were confirmed by other groups that found an alteration in the plasma concentration of STC2 and pregnancy-associated plasma protein A (also known as pappalysin-1 or PAPP-A or PAPPA1) in DM2 patients suffering from cardiovascular diseases [22]. This evidence concerns the gene STC2 and myotonic dystrophy type 2.